Plasma-liquid interactions represent a growing interdisciplinary area of research involving plasma science, fluid dynamics, heat and mass transfer, photolysis, multiphase chemistry and aerosol science. This review provides an assessment of the state-of-the-art of this multidisciplinary area and identifies the key research challenges. The developments in diagnostics, modeling and further extensions of cross section and reaction rate databases that are necessary to address these challenges are discussed. The review focusses on nonequilibrium plasmas.
Byproducts
produced when treating perfluorooctanoic acid (PFOA)
and perfluorooctanesulfonate (PFOS) in water using a plasma treatment
process intentionally operated to treat these compounds slowly to
allow for byproduct accumulation were quantified. Several linear chain
perfluoroalkyl carboxylic acids (PFCAs) (C4 to C7) were identified
as byproducts of both PFOA and PFOS treatment. PFOA, perfluorohexanesulfonate
(PFHxS), and perfluorobutanesulfonate (PFBS) were also found to be
byproducts from PFOS degradation. Significant concentrations of fluoride
ions, inorganic carbon, and smaller organic acids (trifluoroacetic
acid, acetic acid, and formic acid) were also identified. In addition
to PFCAs, PFHxS, and PFBS, trace amounts of 43 PFOA-related and 35
PFOS-related byproducts were also identified using a screening and
search-based algorithm. Minor concentrations of gas-phase byproducts
were also identified (<2.5% of the F originally associated with
the parent molecules) some of which are reported for the first time
in perfluoroalkyl substance degradation experiments including cyclic
perfluoroalkanes (C4F8, C5F10, C6F12, C7F14, and C8F16). The short chain PFCAs detected suggest the
occurrence of a stepwise reduction of the parent perfluoroalkyl substances
(PFAS) molecule, followed by oxidation of intermediates, perfluoroalkyl
radicals, and perfluoro alcohols/ketones. Using a fluorine mass balance,
77% of the fluorine associated with the parent PFOA and 58% of the
fluorine associated with the parent PFOS were identified. The bulk
of the remaining fluorine was determined to be sorbed to reactor walls
and tubing using sorption experiments in which plasma was not generated.
A process based on electrical discharge plasma was tested for the transformation of perfluorooctanoic acid (PFOA). The plasma-based process was adapted for two cases, high removal rate and high removal efficiency. During a 30 min treatment, the PFOA concentration in 1.4 L of aqueous solutions was reduced by 90% with the high rate process (76.5 W input power) and 25% with the high efficiency process (4.1 W input power). Both achieved remarkably high PFOA removal and defluorination efficiencies compared to leading alternative technologies. The high efficiency process was also used to treat groundwater containing PFOA and several cocontaminants including perfluorooctanesulfonate (PFOS), demonstrating that the process was not significantly affected by cocontaminants and that the process was capable of rapidly degrading PFOS. Preliminary investigation into the byproducts showed that only about 10% of PFOA and PFOS is converted into shorter-chain perfluoroalkyl acids (PFAAs). Investigation into the types of reactive species involved in primary reactions with PFOA showed that hydroxyl and superoxide radicals, which are typically the primary plasma-derived reactive species, play no significant role. Instead, scavenger experiments indicated that aqueous electrons account for a sizable fraction of the transformation, with free electrons and/or argon ions proposed to account for the remainder.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.